Clinical trials specifically targeting young patients with breast cancer are necessary
A new Cancer Research UK study revealed a difference in disease relapse rates between younger and older women with estrogen receptor–positive breast cancer who were treated with chemotherapy followed by 5 years of tamoxifen. Study results showed a higher disease relapse rate in younger women after 5 years.
The research suggests that taking tamoxifen for a longer time might benefit younger women. In addition, Cancer Research UK scientists are calling for more clinical trials targeted specifically for young patients with breast cancer to examine other treatment approaches.
The study is published in the Journal of the National Cancer Institute.
Source: Cancer Research UK Press Release.